HIMS & HERS HEALTH INC (HIMS)
US4330001060 - Common Stock
Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys
January 2025 Options Now Available For Hims & Hers Health (HIMS)
Amazon Sets Sights on Both Hims & Hers and Temu. Is This a Golden Opportunity to Buy the Stock?
Guardant Health Stock Sees RS Rating Jump To 83
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83.
Hims & Hers Stock Is Down 30% This Week: Here's What Happened
Hims & Hers has given back recent gains, but don't overlook the company's massive growth.
Should You Buy Hims & Hers Stock on the Dip?
Notable Thursday Option Activity: HIMS, PAG, SNOW
Hims Drops Most Ever as Amazon Enters Hair-Loss Drug Market
Hims & Hers Health Inc. shares dropped the most in their five-year history after Amazon.com Inc. said it would start marketing drugs to fight hair loss, an important component of the telehealth company’s business.
Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue
Up 298% in a Year, Is Hims & Hers Health Still a Buy?
The healthcare company is on fire, and it's still cheap by many measures.
Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review
A Fed rate cut and a slew of big earnings reports filled out a busy week.
After Another Blowout Quarter of Surging Revenue, Is Hims & Hers Stock a Once-in-a-Decade Buy?
Hims & Hers strong performance involves much more than just GLP-1 drugs.
December 27th Options Now Available For Hims & Hers Health (HIMS)
Why HIMS & HERS HEALTH INC (NYSE:HIMS) qualifies as a high growth stock.
Is HIMS & HERS HEALTH INC (NYSE:HIMS) suited for growth investing?
Noteworthy Wednesday Option Activity: HIMS, TRIP, AMBC
Missed Out on Eli Lilly? Buy This Amazing Growth Stock Instead
The company expects to enjoy many GLP-1 tailwinds in 2025.
IBD 50's No. 2 Stock, Hims & Hers, Smashes Estimates On 'Robust' Obesity Trajectory
Hims stock jumped late Monday after the online pharmacy beat expectations.